Mode
Text Size
Log in / Sign up
N/A Completed N=2,793

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients

Patient Reported Outcomes
Source: ClinicalTrials.gov NCT03178045 ↗
Enrolled (actual)
2,793
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcomePrimary: Rates of UCC Visits and Readmissions Between the Team Monitoring and Enhanced Feedback Cohorts up to 30 Days Post-operatively — 31; 38; 44; 60 Participants

Summary

The aim of this study is to understand and improve the experience of patients after surgery by comparing two methods of following symptoms while the patient recovers at home.

Outcome Measures

OutcomeResultp-value
PRIMARY
Rates of UCC Visits and Readmissions Between the Team Monitoring and Enhanced Feedback Cohorts up to 30 Days Post-operatively
31; 38; 44; 60; 32; 39
SECONDARY
Difference in Total Number of Nursing Follow-up Calls Between Team Monitoring and Enhanced Feedback Cohorts up to 30 Days Post-Operatively
3.79; 3.40
SECONDARY
Differences in Total Number of Unplanned Clinic Visits Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
349; 347; 467; 476; 301; 282
SECONDARY
Differences in Total Number of Pain Management Referrals Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
1299; 1302; 10; 11; 1; 1
SECONDARY
Differences in Adverse Events Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
1260; 1258; 47; 56; 3; 0
SECONDARY
Interaction in Participants Anxiety Measured by 3 Items on the Patient Reported Outcome Common Terminology Criteria for Adverse Events Survey (PRO-CTCAE)
0.03; 3.0; 0.15; 2.9; 2.9; 0.11
SECONDARY
Differences in Patient Engagement Between Cohorts at 14 Days Post-Operatively Utilizing the Patient Activation Measure (PAM) and Adjusting for Strata and Pre-Operative PAM Score
3.39; 3.37
SECONDARY
Differences in Patient Engagement Between Team Monitoring and Enhanced Feedback Cohorts at 60 Days Post-Operatively Utilizing the Patient Activation Measure (PAM) and Adjusting for Strata and Pre-Operative PAM Score
3.47; 3.44
SECONDARY
Differences in Caregiver Burden Between Team Monitoring and Enhanced Feedback Cohorts Utilizing the Caregiver Reaction Assessment (CRA).
2.34; 2.44; 1.93; 1.90; 1.71; 1.76

Eligibility Criteria

Inclusion Criteria

  • All patients >18 years of age who are scheduled for ambulatory cancer surgery at JRSC and their caregivers will be eligible for study participation.

Exclusion Criteria

  • Inability to speak English
  • Inability to access a computer, tablet, or mobile phone
  • For patients: not interested in/unable to sign up for the MyMSK Patient Portal
  • For caregivers: Unable to provide an email address
  • Cognitive impairment that prohibits informed consent or understanding of the study protocol
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03178045). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search